IGFBP3 and chronic kidney disease: The total IGF-1 levels in the clinical study varied with recipient age in parallel to those reported in the reference population (Figure 4A), although the levels were slightly higher (Figure 4, E and F), as expected if IGFBP3 levels are higher in CKD/ESKD.